Advertisement

Index by author

October 01, 2016; Volume 359,Issue 1

A

  1. Aaltonen, Niina

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  2. Abagyan, Ruben

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

  3. Abbott, Megan

    1. Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252

  4. Adili, Reheman

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781

  5. Ai, Jing

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799

  6. Al-Khrasani, Mahmoud

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  7. Alonso-Galicia, Magdalena

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  8. Alston, Laurie

    1. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

B

  1. Balac, Natasha

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

  2. Balogh, Mihály

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  3. Banfor, Patricia

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

  4. Benetti, Elisa

    1. Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

  5. Bousquet, Peter

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

  6. Brodeur, Scott R.

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  7. Brown, Nicholas F.

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  8. Bui, Hai H.

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

  9. Bush, Kevin T.

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

C

  1. Can, Adem

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

  2. Cerny, Matthew A.

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  3. Chang, Thomas K. H.

    1. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

  4. Cheer, Joseph F.

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

  5. Chen, Bi

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799

  6. Chen, Gang

    1. Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044

  7. Chen, Y. Eugene

    1. Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034

  8. Chen, Yuchen

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

  9. Chiazza, Fausto

    1. Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

  10. Chiu, Weihsueh A.

    1. Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629

  11. Cichocki, Joseph A.

    1. Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629

  12. Cogan, Derek

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  13. Collino, Massimo

    1. Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

  14. Collins, Gregory T.

    1. Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252

  15. Cornic, Laura

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  16. Corona, Aaron

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  17. Csekő, Kata

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  18. Cutrin, Juan Carlos

    1. Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

D

  1. Das, Aditi

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781

  2. DeWire, Scott M.

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  3. Dluzen, Douglas F.

    1. Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044

  4. Dossou, Katinia S. S.

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

  5. Duignan, David B.

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

E

  1. Eberhardt, Esther

    1. Propacetamol-Induced Injection Pain Is Associated with Activation of Transient Receptor Potential Vanilloid 1 Channels
      Florian Schillers, Esther Eberhardt, Andreas Leffler and Mirjam Eberhardt
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 18-25; DOI: https://doi.org/10.1124/jpet.116.233452

  2. Eberhardt, Mirjam

    1. Propacetamol-Induced Injection Pain Is Associated with Activation of Transient Receptor Potential Vanilloid 1 Channels
      Florian Schillers, Esther Eberhardt, Andreas Leffler and Mirjam Eberhardt
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 18-25; DOI: https://doi.org/10.1124/jpet.116.233452

  3. Eitzman, Daniel T.

    1. Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034

  4. Erickson, Sarah L.

    1. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

F

  1. Fantozzi, Roberto

    1. Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

  2. Felix, John P.

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  3. Ferdinandy, Péter

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  4. France, Charles P.

    1. Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252

  5. Freissmuth, Michael

    1. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884

  6. Frost, Douglas O.

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

  7. Funakoshi, Kodai

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

  8. Fürst, Susanna

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

G

  1. Galindo, Kayla

    1. Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252

  2. Garcia, Maria L.

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  3. Garg, Aditya

    1. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

  4. Gill, Charles

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  5. Gintant, Gary

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

  6. Giricz, Zoltán

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  7. Goldenberg, Anne

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

  8. Gould, Todd D.

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

  9. Gueneva-Boucheva, Kristina

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  10. Guha, Neela

    1. Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629

  11. Guo, Xin

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  12. Guyton, Kathryn Z.

    1. Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629

  13. Gynther, Mikko

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

H

  1. Hampton, Caryn

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  2. Harris, Christopher M.

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

  3. Hart, Michelle

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

  4. Helyes, Zsuzsanna

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  5. Hirota, Simon A.

    1. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

  6. Holinstat, Michael

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781

  7. Hollenberg, Paul F.

    1. Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034

  8. Hopkins, Mandi M.

    1. Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells
      Mandi M. Hopkins, Ze Liu and Kathryn E. Meier
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 124-133; DOI: https://doi.org/10.1124/jpet.116.233379

  9. Hosztafi, Sándor

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  10. Huang, Xi-Ping

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

I

  1. Inami, Keita

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

  2. Ishmael, Faoud T.

    1. Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044

J

  1. Jakupovic, Hermina

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  2. Jiang, Handong

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799

  3. Jones, Spencer B.

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

K

  1. Kaczorowski, Gregory J.

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  2. Kang, Hye Jin

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

  3. Kanno, Shuichi

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

  4. Kedzierska, Ewa

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  5. Kenny, Cynthia Hess

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  6. Khalil, Ashraf M.

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  7. Kim, Youngjae

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

  8. Király, Kornél

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  9. Kohler, Martin

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  10. Korzekwa, Kenneth

    1. Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport
      Priyanka Kulkarni, Kenneth Korzekwa and Swati Nagar
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 26-36; DOI: https://doi.org/10.1124/jpet.116.235689

  11. Kulkarni, Priyanka

    1. Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport
      Priyanka Kulkarni, Kenneth Korzekwa and Swati Nagar
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 26-36; DOI: https://doi.org/10.1124/jpet.116.235689

  12. Kulmacz, Richard

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781

  13. Kumagai, Takeshi

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

L

  1. Lackó, Erzsébet

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  2. Laitinen, Jarmo T.

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  3. Lash, Lawrence H.

    1. Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629

  4. Lau, Aik Jiang

    1. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

  5. Lauver, D. Adam

    1. Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034

  6. Lazarus, Philip

    1. Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044

  7. Leffler, Andreas

    1. Propacetamol-Induced Injection Pain Is Associated with Activation of Transient Receptor Potential Vanilloid 1 Channels
      Florian Schillers, Esther Eberhardt, Andreas Leffler and Mirjam Eberhardt
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 18-25; DOI: https://doi.org/10.1124/jpet.116.233452

  8. Lehtonen, Marko

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  9. Li, Chenhong

    1. Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817

  10. Li, Yixuan

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799

  11. Li, Zhen

    1. Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817

  12. Liu, Henry C.

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

  13. Liu, Jessica

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  14. Liu, Ze

    1. Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells
      Mandi M. Hopkins, Ze Liu and Kathryn E. Meier
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 124-133; DOI: https://doi.org/10.1124/jpet.116.233379

  15. Lun, Christina

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

  16. Luo, Fang

    1. Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817

M

  1. Mani, Sridhar

    1. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

  2. Mastrocola, Raffaella

    1. Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

  3. Matsui, Satomi

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

  4. Mayoux, Eric

    1. Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

  5. McCann, Denis J.

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

  6. Meier, Kathryn E.

    1. Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells
      Mandi M. Hopkins, Ze Liu and Kathryn E. Meier
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 124-133; DOI: https://doi.org/10.1124/jpet.116.233379

  7. Metzger, Joseph M.

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  8. Mittelstadt, Scott

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

  9. Moaddel, Ruin

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

  10. Moss, Neil

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  11. Mousa, Shaaban A.

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  12. Mukherjee, Subhajit

    1. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

N

  1. Nagar, Swati

    1. Intracellular Unbound Atorvastatin Concentrations in the Presence of Metabolism and Transport
      Priyanka Kulkarni, Kenneth Korzekwa and Swati Nagar
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 26-36; DOI: https://doi.org/10.1124/jpet.116.235689

  2. Nagata, Kiyoshi

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

  3. Nanoff, Christian

    1. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884

  4. Nasrollahi-Shirazi, Shahrooz

    1. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884

  5. Navia-Paldanius, Dina

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  6. Nevalainen, Tapio

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  7. Nicoletti, Amy M.

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  8. Nigam, Sanjay K.

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

  9. Nigro, Debora

    1. Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

  10. Norman, Bryan H.

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

  11. Numata, Yoshihiro

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

O

  1. Ormes, James

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  2. Orzelska-Górka, Jolanta

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  3. Osawa, Yoichi

    1. Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034

  4. Owens, Karen

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

P

  1. Pai, Lee-Yuh

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  2. Pan, Qi

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  3. Parkkari, Teija

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  4. Parmentier, Jean-Hugues

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  5. Pasternak, Alexander

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  6. Pfeifer, Lance A.

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

  7. Presky, David H.

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  8. Price, Olga

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  9. Priest, Birgit T.

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

R

  1. Ralph, Kerry L. M.

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  2. Rasa, Cordelia

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  3. Reinhart, Glenn A.

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  4. Riba, Pál

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  5. Rice, Kenner C.

    1. Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252

  6. Richman, Jeremy R.

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  7. Ritchie, Julie

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  8. Rocha, Guilherme

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

  9. Rodriguez, Paul

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

  10. Roy, Jahnabi

    1. Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function
      Jahnabi Roy, Reheman Adili, Richard Kulmacz, Michael Holinstat and Aditi Das
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 134-141; DOI: https://doi.org/10.1124/jpet.116.234781

  11. Roy, Sophie

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  12. Rush, Elise L.

    1. Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine
      Gregory T. Collins, Megan Abbott, Kayla Galindo, Elise L. Rush, Kenner C. Rice and Charles P. France
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 1-10; DOI: https://doi.org/10.1124/jpet.116.234252

  13. Rusyn, Ivan

    1. Target Organ Metabolism, Toxicity, and Mechanisms of Trichloroethylene and Perchloroethylene: Key Similarities, Differences, and Data Gaps
      Joseph A. Cichocki, Kathryn Z. Guyton, Neela Guha, Weihsueh A. Chiu, Ivan Rusyn and Lawrence H. Lash
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 110-123; DOI: https://doi.org/10.1124/jpet.116.232629

S

  1. Saha, Joy K.

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

  2. Sasaki, Takamitsu

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

  3. Savinainen, Juha R.

    1. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
      Niina Aaltonen, Ewa Kedzierska, Jolanta Orzelska-Górka, Marko Lehtonen, Dina Navia-Paldanius, Hermina Jakupovic, Juha R. Savinainen, Tapio Nevalainen, Jarmo T. Laitinen, Teija Parkkari and Mikko Gynther
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 62-72; DOI: https://doi.org/10.1124/jpet.116.233114

  4. Schäfer, Michael

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  5. Schillers, Florian

    1. Propacetamol-Induced Injection Pain Is Associated with Activation of Transient Receptor Potential Vanilloid 1 Channels
      Florian Schillers, Esther Eberhardt, Andreas Leffler and Mirjam Eberhardt
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 18-25; DOI: https://doi.org/10.1124/jpet.116.233452

  6. Segreti, Jason

    1. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
      Christopher M. Harris, Scott Mittelstadt, Patricia Banfor, Peter Bousquet, David B. Duignan, Gary Gintant, Michelle Hart, Youngjae Kim and Jason Segreti
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 151-158; DOI: https://doi.org/10.1124/jpet.116.235002

  7. Shah, Kashmira

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  8. Sucic, Sonja

    1. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884

  9. Sullivan, Kathleen A.

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  10. Sun, Duxin

    1. Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034

  11. Sun, Guangqiang

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799

  12. Sutliff, Aimee K.

    1. Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044

  13. Swearingen, Craig A.

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

T

  1. Tan, Bailin

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

  2. Tang, Haifeng

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  3. Thirunavukkarasu, Kannan

    1. Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis
      Kannan Thirunavukkarasu, Bailin Tan, Craig A. Swearingen, Guilherme Rocha, Hai H. Bui, Denis J. McCann, Spencer B. Jones, Bryan H. Norman, Lance A. Pfeifer and Joy K. Saha
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 207-214; DOI: https://doi.org/10.1124/jpet.116.234013

  4. Thomas-Fowlkes, Brande

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  5. Tong, Vince

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

  6. Toriyabe, Takayoshi

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

V

  1. Váradi, András

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  2. Venkataramani, Sathyadevi

    1. Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
      Amy M. Nicoletti, Cynthia Hess Kenny, Ashraf M. Khalil, Qi Pan, Kerry L. M. Ralph, Julie Ritchie, Sathyadevi Venkataramani, David H. Presky, Scott M. DeWire and Scott R. Brodeur
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 37-44; DOI: https://doi.org/10.1124/jpet.116.236075

  3. Vitarelli, Giovanna

    1. Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
      Elisa Benetti, Raffaella Mastrocola, Giovanna Vitarelli, Juan Carlos Cutrin, Debora Nigro, Fausto Chiazza, Eric Mayoux, Massimo Collino and Roberto Fantozzi
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 45-53; DOI: https://doi.org/10.1124/jpet.116.235069

W

  1. Wainer, Irving W.

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

  2. Wang, Hui

    1. Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034

  3. Wang, Zaijie Jim

    1. Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817

  4. Watson, Christy J. W.

    1. Regulation of UGT2B Expression and Activity by miR-216b-5p in Liver Cancer Cell Lines
      Douglas F. Dluzen, Aimee K. Sutliff, Gang Chen, Christy J. W. Watson, Faoud T. Ishmael and Philip Lazarus
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 182-193; DOI: https://doi.org/10.1124/jpet.116.235044

  5. Weldon, Steven M.

    1. Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates
      Steven M. Weldon, Matthew A. Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss, Jean-Hugues Parmentier, Jeremy R. Richman, Glenn A. Reinhart and Nicholas F. Brown
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 142-150; DOI: https://doi.org/10.1124/jpet.116.236463

  6. Wu, Wei

    1. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach
      Henry C. Liu, Anne Goldenberg, Yuchen Chen, Christina Lun, Wei Wu, Kevin T. Bush, Natasha Balac, Paul Rodriguez, Ruben Abagyan and Sanjay K. Nigam
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 215-229; DOI: https://doi.org/10.1124/jpet.116.232660

X

  1. Xiao, Jianying

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150

Y

  1. Yamazoe, Yasushi

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

  2. Yang, Qiong

    1. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions
      Shahrooz Nasrollahi-Shirazi, Sonja Sucic, Qiong Yang, Michael Freissmuth and Christian Nanoff
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 73-81; DOI: https://doi.org/10.1124/jpet.116.232884

  3. Yin, Pingping

    1. Inhibition of CaMKIIα in the Central Nucleus of Amygdala Attenuates Fentanyl-Induced Hyperalgesia in Rats
      Zhen Li, Chenhong Li, Pingping Yin, Zaijie Jim Wang and Fang Luo
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 82-89; DOI: https://doi.org/10.1124/jpet.116.233817

  4. Yoshida, Midori

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

  5. Yoshinari, Kouichi

    1. Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance–Associated Protein 3 Activation through a Novel Transcriptional Element
      Takamitsu Sasaki, Keita Inami, Yoshihiro Numata, Kodai Funakoshi, Midori Yoshida, Takeshi Kumagai, Shuichi Kanno, Satomi Matsui, Takayoshi Toriyabe, Yasushi Yamazoe, Kouichi Yoshinari and Kiyoshi Nagata
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 102-109; DOI: https://doi.org/10.1124/jpet.115.231589

  6. You, Wenjie

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799

Z

  1. Zádori, Zoltán Sándor

    1. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration
      Erzsébet Lackó, Pál Riba, Zoltán Giricz, András Váradi, Laura Cornic, Mihály Balogh, Kornél Király, Kata Csekő, Shaaban A. Mousa, Sándor Hosztafi, Michael Schäfer, Zoltán Sándor Zádori, Zsuzsanna Helyes, Péter Ferdinandy, Susanna Fürst and Mahmoud Al-Khrasani
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 171-181; DOI: https://doi.org/10.1124/jpet.116.233551

  2. Zanos, Panos

    1. Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
      Adem Can, Panos Zanos, Ruin Moaddel, Hye Jin Kang, Katinia S. S. Dossou, Irving W. Wainer, Joseph F. Cheer, Douglas O. Frost, Xi-Ping Huang and Todd D. Gould
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 159-170; DOI: https://doi.org/10.1124/jpet.116.235838

  3. Zhang, Haoming

    1. Significant Improvement of Antithrombotic Responses to Clopidogrel by Use of a Novel Conjugate as Revealed in an Arterial Model of Thrombosis
      Haoming Zhang, D. Adam Lauver, Hui Wang, Duxin Sun, Paul F. Hollenberg, Y. Eugene Chen, Yoichi Osawa and Daniel T. Eitzman
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 11-17; DOI: https://doi.org/10.1124/jpet.116.236034

  4. Zhao, Angela

    1. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation
      Aditya Garg, Angela Zhao, Sarah L. Erickson, Subhajit Mukherjee, Aik Jiang Lau, Laurie Alston, Thomas K. H. Chang, Sridhar Mani and Simon A. Hirota
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 91-101; DOI: https://doi.org/10.1124/jpet.116.234096

  5. Zhou, Ji

    1. The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor <em>β</em>1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-<em>β</em>1 and Suppresses Tumor Metastasis
      The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis
      Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai and Handong Jiang
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 54-61; DOI: https://doi.org/10.1124/jpet.116.234799

  6. Zhou, Xiaoyan

    1. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter’s Syndrome Type II Phenotype
      Caryn Hampton, Xiaoyan Zhou, Birgit T. Priest, Lee-Yuh Pai, John P. Felix, Brande Thomas-Fowlkes, Jessica Liu, Martin Kohler, Jianying Xiao, Aaron Corona, Olga Price, Charles Gill, Kashmira Shah, Cordelia Rasa, Vince Tong, Karen Owens, James Ormes, Haifeng Tang, Sophie Roy, Kathleen A. Sullivan, Joseph M. Metzger, Magdalena Alonso-Galicia, Gregory J. Kaczorowski, Alexander Pasternak and Maria L. Garcia
      Journal of Pharmacology and Experimental Therapeutics October 2016, 359 (1) 194-206; DOI: https://doi.org/10.1124/jpet.116.235150
Back to top

In this issue

Advertisement